: By analyzing "dosimetry"—the calculation and assessment of the radiation dose received by the human body—his work helps hospitals choose the most effective machinery and software for specific patient needs.

In the evolving landscape of oncology, precision is the primary goal. Researchers like İsmail Hakkı Sarpün are at the forefront of this mission, focusing on optimizing radiation therapy to maximize tumor destruction while sparing healthy tissue. Sarpün’s work often explores the technical boundaries of modern radiotherapy, specifically comparing advanced delivery methods like and Helical Tomotherapy . Breaking Down the Research

Sarpün’s recent studies address critical challenges in treating "locally advanced" cancers—cases where a tumor has spread beyond its original site but remains in the general area. His research provides vital data for clinical decision-making in several key areas:

: One of his notable studies focuses on patients who are ineligible for brachytherapy (internal radiation). He utilizes a "simultaneous integrated boost" technique to deliver higher doses of radiation more accurately using VMAT and Helical Tomotherapy.

The tag is part of an ORCID iD (specifically 0000-0002-9788-699X ), a digital identifier for researchers. This particular ID belongs to İsmail Hakkı SARPÜN , a researcher in the field of Medical Physics and Radiotherapy .

Below is an article summarizing his recent contributions to cancer treatment research.

As a recognized researcher with a verified ORCID profile , Sarpün’s contributions are part of a global, transparent record of scientific progress. His ongoing work continues to push the boundaries of how we use physics to fight one of humanity's most persistent health challenges. İsmail Hakkı SARPÜN (0000-0002-9788-699X) - ORCID